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GBM heparan sulfate alterations in experimental diabetic nephropa-
thy. J. van den Born, A.A. van Kraats, M.A.H. Bakker, KIM. Assmann,
H.B.P.M. Dijkman, J.A. W.M van der Laak and J.H.M Berden, Departments
of Nephrology and Pathology, University of Nijmegen, Nzjmegen, The Neth-
erlands. Heparan sulfate (HS) is the strongly anionic side chain of heparan
sulfate proteoglycan (USPO), the major proteoglycan within the GBM,
responsible for the charge selective permeability of the OHM. To inves-
tigate the possible role of US in diabetic nephropathy (DNP), male
Wistar-MUnich rats (N = 15)were made diabetic by an i.v. injection of 55
mg streptozotocinlkg body wt. Rats were treated by a low dose of insulin
to maintain blood glucose levels between 20—25 mrvilliter. Age matched
rats (N = 5) were used as controls. Albuminuria was measured by rocket
immunoelectrophoresis, the selectivity index was defined as the clearance
of IgO/clearance of albumin. After eight months kidneys were removed
for histology and isolation of the glomeruli. 4-hydroxyproline (4-HP,
collagen content) was measured colorimetrically after hydrolysis of the
glomeruli. OHM US was analyzed using two different methods: (a)
quantitation of the HS content in glomerular extracts by inhibition-ELISA
using anti-OBM HS mAb JM-403; (b) quantitation of the US-associated
anionic sites of the OBM by cuprolinic blue staining and quantitation by
a computerized image analyzer. The US specificity of the staining was
shown by glycosaminoglycan degrading enzymes. The majority of the US
anionic sites were found in the lamina rara externa (LRE) of the OBM.
Results are expressed as means SD or as medians if not normally
distributed. Differences were tested by Wilcoxon's test.
Parameters after S
months of diabetes Diabetic rats Control rats P value
Atbuminuria mg/24 hr 42 13 0.5 0.2 <0.001
Selectivity index 0.20 0.04 0.39 0.17 <0.05
Olomerular US content 314 262 NS
ng/mg gloma
Olomerular 4-UP content 1665 672 <0.01
ng/mg glo&
HS/4-UP ratioa 0.21 0.39 <0.05
LRE US anionic sites 34 5 41 3 <0.05
number/pm GBM
Site surface nm2 147 17 169 32 NS
Relative site surface %b 6.89 1.44 9.36 1.92 <0.05
OHM thickness nm 281 32 239 14 <0.05
On imrnunofluorescence the intensity of OBM staining for laminin was
increased, whereas USPG and US were unchanged. In conclusion, in
experimental DNP a relative, but not absolute decrease of OHM US is
suggested by a decrease of the HS/4-UP ratio, by an increased expression
of laminin in the OHM, and by OBM thickening. Concomitantly, an
absolute decrease of the number and relative site surface of US-associated
anionic sites was found in the LRE of the OBM, indicating a reduced
charge barrier. These results might explain the selective albuminuria and
suggest structural OBM US alterations (reduced charge) in experimental
DNP.
Angiotensin II inhibits the production of heparan sulfate proteoglycans
by human adult mesangial cells in vitro. N.F. van Det, N.A.M. Verhagen,
IT. Tamsma, I van der Born, J.H.M. Berden, IA. Bruzjn, MR. Daha, and
F. van der Woude, University Hospitals Nijmegen and Leiden, Departments
of Endocrinology, Pathology and Nephrology, Nijmegen and Leiden, The
Netherlands. Angiotensin II (Ang IT) is an important molecule in the
regulation of synthesis of extracellular matrix components in mesangial
cells in vitro. Clinical studies have demonstrated that angiotensin convert-
ing enzyme inhibitors protect against deterioration of renal function in
insulin-dependent diabetic nephropathy and induce a decrease in urinary
protein excretion in patients with nephrotic syndrome. A decrease in the
OHM content of negatively charged heparan sulfate proteoglycan (USPO)
could lead to proteinuria and deterioration of renal function in patients
with diabetic nephropathy. We therefore hypothesized that Ang II may be
an important regulator of USPO synthesis. To test this hypothesis we
cultured human adult mesangial cells AMC) for 3 days with increasing
concentrations of Mg II (10"—lO M) in DMEM with 0.5% heat
inactivated fetal calf serum (ÔFCS). After this period the supernatants
were harvested and the number of cells was determined. The production
of heparan sulfate was measured by an inhibition ELISA using monoclo-
nal antibodies which specifically recognize OHM US. Mg TI significantly
decreased the production of US by the cells in a dose-dependent fashion.
This decrease in production was observed up to a concentration of i09 M
Mg II. Cells cultured in 0.5% 5FCS produce 36.8 sg US/106 cells versus
cells cultured in 0.5% SFCS + 10—6 M Mg II produce 10.75 &g US/106
cells (P < 0.02). Experiments using cycloheximide revealed that US was
synthesized de novo. This Mg Il-mediated decrease in US production was
inhibited by the AT1 receptor antagonist DuP-753 (10—6 54). These data
suggest that Mg TI induces an inhibition of US production by AMC in
vitro and that AT1 receptors may play a role in this process.
Decrease of heparan sulfate staining in the glomerular hasement
membrane in murine lupus nephritis. Correlation with albuminuria and
glomerular immunoglobulin deposits. M C.I van Bruggen, C. Kramers,
MN. Hylkema, I van den Born, M.A.H. Bakker, KIM Assmann, Ri. T
Smeenlç and IH.M Berden, Departments of Nephrology and Pathology,
University Hospital Nijmegen, Nijmegen, and Department of Autoimmune
Diseases, CLB, Amsterdam, The Netherlands. Loss of heparan sulfate (US)
associated anionic sites has been implicated in the development of
albuminuria. Recently, we found in biopsies of human lupus nephritis a
nearly complete loss of US staining in the OHM. To clarify the relation-
ship between US staining and albuminuria in lupus nephritis, we studied
MRL/lpr mice with short (<7 days) or prolonged duration of albuminuria
(14—21 days) and compared them with age matched controls without
albuminuria (N = S per group). Kidney sections were stained for mouse
Ig, US and heparan sulfate proteoglycan (USPO)-core protein by immu-
nolluorescence (IF). In mice with prolonged albuminuria US staining in
the glomerular capillary loops had almost completely disappeared,
whereas staining was unaltered in non-albuminuric mice. In mice with
short duration of albuminuria, there was a tendency towards a decrease of
US staining (P = 0.06). The expression of USPO-core protein was
unaltered in all groups. US staining correlated inversely with albuminuria
(r, = —0.55; P < 0.001) and with staining of Ig deposits in the capillary
loops (r = —0.74; P < 0.001). Despite the nearly complete loss of US
staining in the OHM in mice with prolonged albuminuria, there was no
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Median value; b (total site surface/LRE surface) x 100%
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change in glomerular HS content as assessed with an inhibition ELISA in
extracts of pooled isolated glomeruli in the different groups. Results are
given in the Table [mean SD or median (range)].
No
albuminuria
Recent
albuminuria
Prolonged
albuminuria
IF staining GBM
Mouse Ig 1.3 0.7 1.8 0.8 2.4 0.7a
HS 2.7 0.6 1.9 0.8 0.5 0.2
HSPG-core 3.3 0.3 3.0 0.3 3.1 0.3
HS content pg/glomerulus 81 105 87
albuminuria 52 1700 4800
pg/18 hours (20—104) (1200_21400)a (2100_23800)a
a P < 0.05 compared with non-albuminuric age matched controls
We conclude that the development of albuminuria in MRL/lpr mice is
paralleled by a loss of HS staining in the GBM which is probably due to
masking of HS by deposits of 1g.
Glomerular pressure (P) and tubuloglomerular feedback (TGF) in
Nagase analbuminenic rats (NAR). B. Braam, J.A. Joles, J. Grond, and
HA. Koomans, Department of Nephrology, University Hospital Utrecht,
Utrecht, Department of Pathology, University Hospital Groningen, Gronin-
gen, The Netherlands. The 9 NAR as compared to NAR displays severe
hyperlipidemia. The 9 uninephrectomized (UnX) NAR develops protein-
uria and glomerulosclerosis (GS), in contrast to the UnX NAR. As
increased P0 is generally considered to be a major risk factor in the
development of GS, we evaluated glomerular hemodynamics and TGF
responsiveness in two-kidney (2K) and UnX, d and 9 NAR at a moment
shortly before proteinuria develops; 13—15 weeks following UnX or
sham-operation, rats were anesthetized (pentobarbital, 50 mg/kg body wt)
and prepared for micropuncture. Late proximal tubular fluid samples were
collected and stop-flow (SFP), star vessel and free flow pressure were
assessed. Furthermore, maximum TOF-mediated decreases in SFP (ASF-
Pm,,) were evaluated by late proximal perfusion with artificial tubular fluid
(at 40 in 2K and 80 nI/mm in UnX rats).
9UnXN=5 92KN=6 UnXN=5 12KN=6
Flow1,, nI/mm 27.3 1.4° 16.8 10b 32.9 2.8° 24.8 2.8
SNGFR nI/mm 38.7 4.1k' 29.7 19b 60.3 8.2 46.5 5.2
mm Hg 59.4 3.9 55.8 2.3 57.0 1.5° 50.3 1.4
Kf nl/(s 0.025 0.004 0.020 0.002" 0.033 0.004 0.034 0.004
mm Hg)
IXSFPm,,
mm Hg
6.5 09b 9.8 0.7 13.7 2.7 12.8 1.7
Viizm,, ni/mm 35 4° 19 1 33 4° 18 2
ap < 0.01 vs. 2K; bp < 0.05 vs. LP, late proximal; Vii2m, late
proximal perfusion rate eliciting a half maximal TGF response
Plasma cholesterol was 7.1 0& and 7.1 0.3" in UnX and 2K 9 and
5.5 0.3° and 4.2 0.3 mat in UnX and 2K d rats. Plasma triglycerides
were 5.5 07b and 6.5 1.4" in UnX and 2K 9 and 1.8 0.2 and 1.5
0.3 m in UnX and 2K rats. Hyperfiltration, glomerular hypertrophy,
and arterial pressure were comparable in 9 and MARs. In the 9 UnX
rats, no increase in P0 could be demonstrated. TGF behavior in response
to UnX differs between and 9 UnX rats. The present study, together
with previous data, suggests that in 9 UnX MAR, plasma lipid composi-
tion forms a major risk factor for the development of US.
Identification of Rf-1, a gene responsible for renal failure in the
fawn-hooded (FHH) rat. A.P. Provoost, D.M. Brown, MJ. Daly, ES.
Lander, and H.J. Jacob, Department of Pediatric Surgeiy, Erasmus Univer-
sity, Rotterdam, The Netherlands, Cardiovascular Research Center, Massa-
chusetts General Hospital/Harvard Medical School, Charlestown, Massachu-
setts, and Whitehead Institute for Biomedical Research/Massachusetts
Institute of Technology Genome Center, Cambridge, Massachusetts, USA.
End-stage renal disease (ESRD) is a serious potential complication of
hypertension, although only a minority of hypertensive patients develop
ESRD. We have investigated the relationship between hypertension and
ESRD using the genetically hypertensive fawn-hooded (FHH) rat. Previ-
ous studies in the FHH have suggested that systemic and/or glomerular
hypertension was the primary cause of renal failure as defined by
proteinuria and focal glomerular sclerosis. We approached the interaction
between hypertension and renal failure using molecular genetics. Linkage
analysis was performed in a genetic cosegregation study using the FHH
and the normotensive non-proteinuric ACT rat. A total of 84 genetic
markers, covering at least 50% of the rat genome, was genotyped in the
male backcross F1(FHH X ACT) X FHH progeny. These animals were
analyzed for linkage with a macroscopic renal sclerosis score (RSS),
proteinuria, and systolic blood pressure (SBP). Strong evidence was found
for a locus, named renal failure 1 (Rf-1) on chromosome 1, that is
responsible for 55% of the total variance in RSS, and 36% of the variance
in proteinuria. Interestingly, the region was found to have no significant
effect on SBP. We did, however, locate another locus accounting for 15%
of the variance in SBP, which also mapped to chromosome 1. This locus
appeared to contain the SA gene, but it failed to account for any variance
in the renal failure phenotypes. These results seem to imply that devel-
opment of hypertension-associated renal damage does not result simply
from the effects of systemic hypertension on the kidney, but also involves
the presence of other genetic susceptibility factors. In this respect, our
study is the first to demonstrate that the genetic predisposition to renal
failure appears to be a disease within a disease.
Effects of Ca2 channel blockers, low Ca2+ medium and glycine on cell
Ca2 and cell injury in anoxic rabbit proximal tubule cells. G.M. Rose,
R.J.M Bindels, and C.H. van Os, Department of Physiology, University of
Nijmegen, Nijmegen, The Netherlands. L-type Ca2 channel blockers
(CCBs) have been shown to be protective against ischemia-induced injury
of the kidney, suggesting that increased intracellular Ca2 levels ([Ca2]1)
play an important role in the pathogenesis of ischemic cell injury. To
assess the role of [Ca2]1 in anoxic injury of the proximal tubule (PT) and
the protective effect of CCBs, [Ca2]1 was monitored in individual PT cells
during 60 minutes of anoxia. PT cells were attached to Cell-Take coated
coverslips and subsequently loaded with fura-2 AM and mounted in an
anoxic chamber at 37°C. [Ca2] was measured using digital imaging
fluorescence microscopy. During anoxia, [Ca2] started to rise within 10
minutes, reaching a maximal level between 30—45 minutes of anoxia. The
onset of this increase and the maximal levels reached varied markedly
among individual cells. The mean values for initial and maximal anoxic
[Ca2] were 109 2 and 422 14 flM, respectively. Methoxyverapamil
(D600; 1 ILM) significantly reduced anoxic [Ca2] to 122 5 nat (P <
0.05). Removal of extracellular Ca2 completely abolished anoxia-induced
increases in [Ca2]1, confirming that these increases in [Ca2]1 result from
Ca2 influx. During 60 minutes of anoxia, PT cells showed a gradual
decrease in cell viability to 54 2%. D600 (1 sM) significantly increased
cell viability to 64 3% (P < 0.05). Low Ca2 medium only protected
when 0.1 mat La3 was included, which condition increased cell viability to
82 5%. La3 did not enter PT cells and probably protects via a
membrane-stabilizing effect. Glycine (5 mM), however, increased cell
viability to 77 4% without a significant reduction in anoxic [Ca2I1. The
combination of glycine and La3 did not further increase the protection.
In conclusion, D600 almost completely prevented anoxia-induced in-
creases in [Ca2]1 by blocking Ca2 influx via L-type Ca2 channels. Since
D600 only partly protected PT cells against anoxic injury, [Ca2], unre-
lated cell injury, which is attenuated by glycine, is a more prominent factor
in anoxia-induced cell injury in rabbit PT cells.
The dihydropyridine calcium entry blocker felodipine and its non-
calcium blocking derivative H186/86 attenuate hypoxia-induced cell in-
jury in isolated rat proximal tubules. S.M.A. Peters, M.J.A. Tijsen, R.J.M.
Bindels, RAP. Koene, C.H. van Os, and J.F.M Wetzels, Department of
Physiology, University of Nijmegen, and Department of Nephrology, Univer-
sity Hospital Nijmegen, The Netherlands. The hypothesis that calcium influx
into hypoxic renal proximal tubules participates in the development of cell
injury is mainly based on the observations of the protective effects of the
phenylalkylamine calcium entry blocker verapamil. We have studied the
effects of the dihydropyridine calcium entry blocker felodipine. To disso-
ciate the protective effects from the calcium blocking properties, we also
studied the effects of the felodipine derivative H186/86, which has no
calcium-antagonistic properties, on hypoxia-induced injury. Freshly iso-
lated rat proximal tubules were incubated in a modified Krebs-Henseleit
buffer (calcium 1.0 mM) under normoxic (95% 02, 5% C02) or hypoxic
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conditions (95% N2, 5% C02) for 30 minutes. Hypoxia caused significant
cell injuiy as reflected by the release of LDH (control 26.6 2.2%,
hypoxia 67.6 2.0%; means SEM, P < 0.01). Both felodipine (100 jM)
and H186/86 (100 M) attenuated cell injury (LDH release 38.2 3.0%
and 50.3 2.5% respectively, P < 0.01 vs. hypoxia). No protection was
observed with 10 M felodipine (LDH release 72.0 3.0%). The
protective effect of felodipine was accompanied by a better preservation of
cell potassium under hypoxic conditions. Lowering of extracellular cal-
cium (10 M) did not prevent but rather enhanced hypoxic cell injury
(LDH release 78.2 4.0% vs. 68.2 2.0%, P < 0.05). Both felodipine and
H186/86, in protective concentrations, increased intracellular potassium
levels in control normoxic tubules (control 200 9, felodipine 250 17,
H186/86 260 9 nmol/mg protein, both P < 0.01). During normoxia,
felodipine, but not H186/86, caused cell injury (LDH release: control 26.2
2.2%, felodipine 43.8 3.7%, H186/86 28.4 2.9%). In conclusion, the
dihydropyridine calcium entry blocker felodipine protects isolated rat
renal tubules against hypoxic cell injury only at very high concentrations.
Together with our observations that the derivative H186/86 also affords
protection, and that low medium calcium is not protective at all, this
strongly suggests that the protective effect of felodipine is not mediated by
blockade of calcium entry. Preservation of cell potassium might contribute
to the effects observed.
Renin-angiotensin system components in the cardiac interstitial fluid.
Uptake from plasma and local production. L.M, De Lannoy, A.H.J.
Danser, R.G. Schoemaker, P.R. Saxena, and M.A.D.H. Schalekamp, Depart-
ments of Internal Medicine I and Phannacology, Erasmus University,
Rotterdam, The Netherlands. To study the cardiac uptake of the renin-
angiotensin system (RAS), components from plasma, as well as their local
synthesis, isolated rat hearts were perfused with renin (R), angiotensino-
gen (Ao), Ang I (Ang I) and Ang 11 (Ang II), using a modified
Langendorif model. This model allowed us to collect separately the
coronary effluent (CE) and interstitial fluid (1SF), which drips from the
heart during perfusion. Each RAS component was infused in 5—7 heart
preparations. Ao was infused for 30 minutes, and R, Ang I and Ang II for
15 minutes. CE (1 minute fractions) and 1SF (single drops) were contin-
uously collected. Prior to their infusion, R, Ao, Ang I and Ang II were
below the detection limit in CE and 1SF. Ao entered the 1SF slowly during
its infusion, like other serum proteins (steady-state levels in >25 minutes).
In contrast, R reached steady-state levels within 10 minutes and could still
be detected in 1SF, but not CE, 10 minutes after R infusion had been
stopped. In addition, the R levels in 1SF were 2—3 times those in CE,
whereas Ao in 1SF rose to 75% of the level in CE. Infused Ang I and Ang
II reached steady-state levels in 1SF within 2 minutes and disappeared
within 2—3 minutes after the infusion had been stopped. During Ang I
infusion, the steady-state level of Ang I in 1SF was 25% of that in CE, and
during Ang II infusion the Ang II level in 1SF was 55% of that in CE. Ang
I infusion resulted in the appearance of Ang II in 1SF and CE, and during
Ang I infusion, the steady-state Ang II levels in 1SF were slightly higher
than those in CE. During R infusion Ang I and Ang II appeared in 1SF in
concentrations 5—10 times higher than in CE. Our results indicate that: (1)
in vivo, part of Ang I and Ang II in the cardiac interstitium is produced in
the heart; (2) renin is rapidly taken up by the heart from the circulation,
possibly by an active process; and (3) intracardiac Ang I production
depends on renin from the kidney.
Does the renin.angiotensin system determine the renal and systemic
response to sodium in essential hypertension? P. van Paassen, D. de
Zeeuw, and P.E. de Jong, University Hospital Groningen, Groningen, The
Netherlands. Many patients with essential hypertension (EH) respond to a
high dietary sodium intake with a rise in blood pressure (BP). Experimen-
tal evidence suggests that the renal hemodynamic response to HS deter-
mines, at least partially, this rise in BP. To clarify the role of the
renin-angiotensin system (RAS) in the renal and systemic hemodynamic
adaptation to a change in dietary sodium, we studied mean arterial
pressure (MAP, mm Hg), effective renal plasma flow (ERPF, mi/mm/I .73
m2), body weight (body wt, kg), and immunoreactive renin (irR, pglml) in
17 EH and 15 normotensive controls (NT), on a sodium restricted (50
mmol, LS) and a sodium replete diet (200 mmol, HS), both for three
weeks (random crossover, placebo controlled), as well as after renin-
inhibition by Remikiren (REM, 600 mg, single oral dose) during the high
sodium diet. In NT, HS had no effect on MAP (90 ito 88 2) or body
wt (72 2 to 72.6 2), whereas ERPF increased (490 19 to 535 21,
P < 0.05) and irR decreased (31.8 5.6 to 14.1 1.4, P < 0.05). In EH,
HS induced a heterogeneous response of MAP (110 2 to 114 2, NS),
ERPF (424 21 to 451 25, NS) and irR (18.1 3.1 to 10.1 1, P <
0.05), with an increase in body wt (81.3 1.9 to 82.5 2, P < 0.05).
Interestingly, the patients with a distinct rise in MAP showed a blunted
ERPF response and irR response to HS (r 0.72, P < 0.01 and r = 0.70,
P < 0.01, respectively). Moreover, the change in ERPF correlated
negatively with the change in irR (r = 0.71, P < 0.01). After REM a
varying rise in ERPF (451 25 to 464 23, NS) was observed: the
patients with the blunted ERPF response to HS showed the largest ERPF
rise (r = 0.69, P < 0.01). The REM-induced rise in ERPF correlated (r =
0.68, P < 0.01) with the fall in MAP (114 2 to 110 2). In conclusion,
in EH a rise in blood pressure in response to a high sodium intake appears
to partially be the result of an insufficient renal vasodilation. This seems to
be the result of an inadequate (intrarenal?) RAS response.
Prognostic significance of severe interstitial edema with minimal
infiltrate in renal allograft biopsies. M.J.J. T Bogman, Ph.MM Dooper,
A.J. Hoitsma, KJ.M Assmann, and RAP. Koene, Departments of Medicine
and Pathology, University Hospital Nijmegen, Nijmegen, The Netherlands.
Percutaneous renal allograft biopsies show in 5—10% of the cases severe
localized or diffuse interstitial edema with only minimal interstitial infil-
trate. Based on diagnostic features such as intimal arteritis, tubulitis,
and/or infiltrate in other areas of the biopsy in most cases a histological
diagnosis of acute rejection (AR) can be made. In cases with diffuse
edema in which no arteries are found, the diagnosis often remains
uncertain. We tested whether severe edema with little or no infiltrate in
(part of) the biopsy is associated with an unfavorable response to
treatment and a higher incidence of graft failure, For this we screened
consecutive allograft biopsies, taken over a 3 year period, for the presence
of severe interstitial edema, defined as a cortical area in which at least 10
adjacent tubuli are separated by intertubular spaces of more than 1
tubular diameter in width, and filled with serous fluid in which no or only
very few mononuclear cells are seen. In a series of 292 adequate renal
cortical graft biopsies, 26 cases (8.9%) showed severe edema, that was
localized in 20 cases, and diffuse (that is, over more than 80% of the biopsy
area) in 6 cases. In 24/26 cases the histological diagnosis was AR grade
I—Ill (Banif Classification). The 2 remaining cases showed borderline
changes with minimal tubulitis, in 1 case accompanied with membranous
nephropathy and transplant glomerulopathy, and in both cases with
interstitial fibrosis suggestive of chronic rejection. In 13/26 biopsies with
edema medium-sized or larger arteries were seen, and in 12 cases (92%)
these showed intimal fibrosis, that in 9/12 was accompanied with acute
intimal arteritis. One biopsy contained arteries without pathological
changes. Apart from the case with membranous nephropathy all patients
received anti-rejection therapy. In the edema group the percentage of
graft failure due to rejection within 12 months was 26.3% and within 3
years 41.7%. In a control group of 86 patients who underwent a graft
biopsy in the same period, had similar histological diagnoses (AR grade
I—Ill or borderline changes), and received similar treatment, these figures
were 17.3% and 22.4%, respectively (P < 0.02, log rank test). We conclude
that in renal allografts, biopsy areas of severe edema without cellular
infiltration are an unfavorable diagnostic sign, probably related with
vascular obliteration due to chronic rejection with superimposed acute
vascular rejection in most cases. It is associated with an increased risk of
immunological graft failure. There is, however, insufficient indication for
withholding anti-rejection treatment.
Renal allograft biopsies (RB) taken during rejection (R): Differences
between interstitial (I) and vascular (V) rejection (R). M.F. Kooijmans-
Coutinho, J.A. Bnujn, J. Hermans, E. Schrama, LA van Es, MR. Daha,
and F.J. van der Woude, Leiden University Hospital, Leiden, The Nether-
lands. Histology (H) and immunohistology (IH) were performed to study
the mechanisms underlying various forms of rejection. We recently
described a relationship between anti-endothelial cell antibody dependent
cellular cytotoxicity and yR. From 50 patients 67 evaluable RB were
obtained. RB were taken at a time when clinically graft R was suspected.
The RB were divided into 3 groups: IR N = 42, VR N = 18 and "diffuse
clotting" (DC) N = 7, groups no 1, 2 and 3 respectively. IH analyses were
performed on the RB from groups 1 and 2, with monoclonal antibodies
directed against leukocytes (CD45), monocytes (WT14), complement
factor 3 (C3), T cells (Leu4), T cell receptor a3 and Fb, tumor necrosis
factor a (TNFa), IL-2 receptor (TAC), intercellular adhesion molecule-I
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(ICAM-1), and HLA-DR. The slides were scored semiquantitatively by 2
independent observers, who had no knowledge of patient or clinical data.
The occurrence of the histological parameters interstitial edema, conges-
tion of peritubular capillaries (PTC), glomerular clotting, and glomerular
ischemia differed significantly between the 3 groups: (3 > 2 > 1) (P =
0,012, 0.0003, 0.00000 and 0.017 for the aforementioned parameters,
respectively); interstitial bleeding was seen more often in DC and VR
compared with JR (P = 0.0003). VR was associated with CD45 positive
cells in the peritubular capillaries (PTC) in only 1/6 (P = 0.04), and WT14
positive cells in the PTC in 5/7 RB with VR (P = 0.01). C3 staining was
positive in 4/6 patients with VR (P = 0.03). The demographic aspects of
the 3 groups were comparable, except for the titers of panel reactive
antibodies (PRA) in pretransplant sera: highest PRA were 26.1 27.6,
38.1 33.7 and 78.4 19.7% (mean SD) in groups 1, 2 and 3,
respectively (P = 0.001). PRA Current were 11.7 19.5, 14.9 22 and
40.3 29.3%, respectively (P = 0.006). The mean number of rejection-
episodes per patient was 1.7, 2.8 and 3.3, respectively. Graft loss occurred
in 7/30 patients from group 1, 10/16 from group 2, and 4/4 from group 3
(P 0.001) (follow-up period 21—57 months). Conclusion: High titers of
PRA before renal allografting are associated with more and more serious
forms of rejection. Graft clotting and vascular rejection carry a poor
prognosis, and immunohistology of vascular rejection is compatible with
an antibody-mediated pathogenesis.
Renal hemodynamics and the renin-angiotensin system in psoriasis
patients during cyclosporine treatment. MA. van den Dorpel, R.JA. de
Bniin, G.J. Wenting, F. Boomsma, F.H.M. Derlcç, and M.A.D.H. Schale-
kamp, Department of Internal Medicine I, Erasmus University, Rotterdam,
The Netherlands. Cyclosporine (C5A) treatment in transplant patients
often leads to hypertension and impaired renal function. Studies of the
underlying mechanism in these patients may be confounded by preexisting
renal failure and cardiovascular disease, graft denervation, or the use of
concomitant medication. We therefore studied the effects of CsA in
psoriasis patients (N = 12) who were otherwise healthy. During the first 3
months CsA dose was 5 mg/kg/day (high dose), followed by 6—18 months
of 2 mg/kg/day (low dose). Mean arterial pressure (MAP), glomerular
filtration rate (GFR), effective renal plasma flow (ERPF), renal vascular
resistance (RVR) and hormones were measured at baseline, at the end of
both CsA dosage regimens and 3 months after cessation of CsA treatment.
Results were as follows (mean SD):
Study
period
MAP
mm Hg
GFR
mi/mm
ERPF
mi/mm
RVR
dynes s
cm5
Active renin
U/ml
Prorenin
UIml
Before 88 8 135 36 684 243 11,675 3,929 22.2 8.3 231 131
CsA
High 97 T 106 isa516 120 15,958 4,258a 15.3 54 357 132
dose
CsA
Low 93 8 109 20 494 132 15,867 3,935a 17.4 8.5k 235 61
dose
CsA
After 84 18 126 23 550 149 13,523 3,678 28.2 13.6 207 75
CsA
a p < 0.05, Kruskal-Wallis one-way ANOVA
CsA treatment increased arterial pressure and reduced GFR and ERPF.
Effects were still present 3 months after CsA had been stopped. CsA
significantly reduced renin but increased prorenin. Our results demon-
strate marked blood pressure elevation and intrarenal vasoconstriction by
CsA in subjects with normal cardiovascular and renal function. This effect
is not caused by renin stimulation. CsA treatment may interfere with
prorenin to renin conversion.
Renal function after lung transplantation. G.J. Navis, H. Potthoj/ W.
van de Bij, G.P.M. Mannes, W.J. de Boer, and P.E. de Jong, Division of
Nephrology and Pulmonology, Department of Internal Medicine and Depart-
ment of Thoracic Sutgeiy, University Hospital, Groningen, Groningen, The
Netherlands. In patients with terminal respiratory failure, lung transplan-
tation (LTx) improves life expectancy. The nephrotoxicity of the thera-
peutic regimen (including cyclosporine A, ATG and co-trimoxazole) has
not been well-defined for these patients. We therefore included renal
function measurements (clearances of 1311-Hippuran and 1J-iothalamate,
for ERPF and GFR, respectively) in the pre- and post-LTx evaluation of
LTx patients. Of 32 patients transplanted between April 1991 and
December 1993, 2 patients died from primary graft failure, and 3 patients
died from pulmonary causes after 3, 6, and 7 months, respectively. The
results of the patients available for renal follow-up are listed below:
Median GFR ERPF MAP
(range) N mI/mm/I. 73 m mi/mm/i. 73 m2 FF mm Hg
30pre-LTx 103 391 0.27 95
(63—160) (135—683) (0.2—0.46) (80—107)
Post-transplantation % change from pre-LTx value
1 month 30 _loa 0 5a 8b
(—66 18) (—66 43) (—47 25) (—8 53)
6 months 20 _21b —12 17b 14b
(—70—0) (—51 53) (—52 18) (—8 50)
12 months 16 31b —13 23b 14b
(—57—0) (—47 42) (—43 18) (—6 48)
a p < 0.05; h P < 0.01, paired Wilcoxon test vs. pre-transplant value
Thus, a decline in GFR was apparent 1 month after LTx, with a further fall
after 6 and 12 months. Urinalysis remained normal in all patients.
Antihypertensive treatment was needed in 8 patients after 12 months.
Pre-LTx GFR was mildly impaired (60—90 mI/mm), without other signs of
renal disease in 8 patients. Pre-LTx GFR and ERPF were negatively
correlated with the post-LTx changes in GFR (r = —0.70; P < 0.01) and
ERPF (r =
—0.87; P < 0.001), respectively. Thus, the renal function
decline after LTx was less pronounced in patients with pre-LTx renal
function impairment. This contrasts with the common finding of greater
renal vulnerability in the presence of impaired renal function in other
populations. Post hoc analysis of our data suggests that this is due to a
particular feature of the renal function impairment in pre-LTx patients: in
all patients with impaired pre-LTx GFR intense renal vasoconstriction was
present, that was partially reversible after LTx. In conclusion, a significant
decline in renal function and a rise in blood pressure occur after LTx,
presumably due to nephrotoxicity of the therapeutic regimen. Neverthe-
less, pre-LTx renal function impairment, characterized by intense renal
vasoconstriction and the absence of urinary abnormalities, should not be
considered a contra-indication for LTx.
Interleukin-la and tumor necrosis factor-a up-regulate, while interfer-
on-y down-regulates the production of interleukin-8 by human proximal
tubular epithelial cells. J.S.J. Gerritsma, F.J. van der Woude, A.F. Gemtsen,
W. Prodjosudjadi, P.S. Hiemstra, LA. van Es, and M.R. Daha, Departments
of Nephrology, and Pulmonology, University Hospital Leiden, Leiden, The
Netherlands. Renal interstitial inflammation is a principal cause of both
native and allograft kidney failure. A number of inflammatory kidney
diseases are associated with interstitial nephritis and influx of both
mononuclear and polymorphonuclear (PMNs) leukocytes in the renal
interstitium. Potentially, the influx of PMNs in the interstitium may be
induced by chemotactic complement fragments, lipid mediators, or cyto-
kines such as interleukin-8. There is evidence that proximal tubular
epithelial cells (PTEC) express JL-8 in situ during inflammation, In the
present study we have analyzed the production of IL-8 by cultured PTEC
in response to a number of inflammatory cytokines such as IL-la, TNF-a
and IFN-y. Primary PTEC cell lines obtained from different kidneys were
cultured under serum-free conditions and assessed for IL-8 production
using an inhibition radioimmunoassay. The minimal level of detection is
0.2 ng IL-8 per ml. PTEC in medium alone produce IL-8 to different
degrees. Some cell lines barely produced a detectable level of IL-8 while
other cell lines produced up to 7.7 0.1 ng IL-8/105 cells/72 hours.
Immunoblotting experiments indicate that the size of IL-8 of PTEC is
10—12 kD and in a chemotactic assay it was shown that the IL-8 produced
by PTEC was chemotactic for PMNs. The presence of IL-la in the culture
media of PTEC induced a dose-dependent up-regulation of IL-8 reaching
maximal levels at an input of 0.5 ng IL-In/mi. TNF-a also induced a
dose-dependent up-regulation of IL-8; the maximal level was reached at
an input of 1000 U/mI TNF-a. In contrast to IL-la and TNF-a, JFN-y
down-regulated the production of IL-8 in a dose-dependent fashion.
Maximal inhibition of 98 0.5% was reached with 1000 U/mI IFN-y.
Taken together, these experiments indicate that PTEC are a source for
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IL-8 in the kidney and that IL-8 produced in the proximal tubule is
induced by various inflammatory cytokines and may be responsible for the
recruitment of polymorphonuclear leukocytes into the kidney.
Role of TNF receptors and protein kinase C (PKC) in the induction of
the verocytotoxin receptor, Gb3, in human endothelial cells. N C.AJ. van
de Kar, T Kooistra, L.A.H. Monnnens, and V. W.M. van Hinsbergh, Gaubius
Laboratorium TNO-PG, Leiden, and Department of Pediatrics, Sint Rad-
boud Hospital, Nijmegen, The Netherlands. Infections with verocytotoxin
(VT) producing E. coli infections have been strongly implicated in the
epidemic form of hemolytic uremic syndrome (HUS). Endothelial damage
plays a central role in the pathogenesis of HUS, In vitro studies have
shown that VT can damage endothelial cells after interaction with a
cellular receptor, which has been identified as globotriaosylceramide
(Gb3). TNFa and IL-i potentiate the toxic effect of VT by inducing an
increase in VT receptors (Gb3) on endothelial cells. The TNFa-induced
increase in VT-receptors was prevented by the protein synthesis inhibitor
cycloheximide. This study further investigates the mechanisms underlying
the increase in endothelial VT receptors induced by TNFa. To investigate
which proteins were involved in this induction, endothelial cells were
incubated with and without TNFx in the presence of '4C-galactose or
14C-glucose. TLC analysis of the glycolipid extracts of these cells demon-
strated a markedly enhanced incorporation of '4C-galactose and in Gb3
and other galactose-containing glycolipids, suggesting that TNFa en-
hanced galactosyl-transferase activity(ies). To examine the role of the 2
recently cloned TNF receptors (TNFR75 and TNFR55) in the TNFa-
induced increase in Gb3 in human endothelial cells, cells were incubated
with TNFa or a TNFa mutant that only recognizes and stimulates
TNFR55. The effect of TNFa, determined by binding experiments with
'251-VT-i, could be largely, but not completely, mimicked by the TNFa
mutant. A contribution of the TNFR75 was mainly present during the first
hours of incubation. A role for PKC activity in the signaling pathway for
TNFa was investigated. Activation of PKC by phorbol ester could partly
mimic the effect of TNFa. The involvement of PKC in the TNFa-
mediated increase in VT-i receptors was further demonstrated by the
specific PKC inhibitor Ro3i-8220. Our results indicate that the increase in
VT receptors on endothelial cells by TNFa mainly occurs via the TNFR55
and depends on PKC activity.
The production of monocyte chemoattractant protein-i by human
proximal tubular epithelial cells is up-regulated by interleukin-ia and
tumor necrosis factor a. W. Prodjosudjad4 1Sf. Gerritsma, N. Kiar-
Mohama4 A.F. Gerritsen, J.A. Bruijn, MR. Daha, and LA van Es,
Departments of Nephrology and Pathology, University Hospital Leiden,
Leiden, The Netherlands. Impairment of renal function in various types of
glomerular disease is associated with infiltration of mononuclear cells in
the interstitium, tubular atrophy, and interstitial fibrosis. Macrophages
may play an important role in the damage of renal tissue through the
production of various cytokines and growth factors, The mechanism of
mononuclear cell infiltration in the interstitium is not fully understood, but
it is likely that chemotactic factors and adhesion molecules are involved.
Monocyte chemoattractant protein-i (MCP-1) has recently been reported
to have a high degree of specificity as a chemotactic factor for monocytes.
We analyzed the presence of MCP-1 in renal biopsies of patients with
various forms of glomerulonephritis and demonstrated that MCP-1 ex-
pression is increased in renal tubular epithelial cells during disease. To
further analyze whether renal tubular epithelial cells are able to produce
MCP-1, proximal tubular epithelial cells (PTEC) were obtained from 6
different kidneys and were cultured in vitro under serum free conditions in
the presence or absence of the inflammatory cytokines IL-la and TNFa.
PTEC in culture produced 2.23 0.87 ng/24 hours/I o cells of MCP-1 and
the presence of IL-la and TNFa enhanced the production by each cell
line in a dose- and time-dependent manner. Optimal levels of MCP-i
production were found with 250 pg/mI and 250 U/ml of IL-Ia and TNFa,
respectively. PTEC cultured in medium containing 250 pg IL-ia/ml or 250
U TNFa/ml enhanced the production of MCP-1 up to 6.42 0.05 ng/24
hours/105 cells and 5.19 1.03 ng/24 hours/105 cells as measured by
radioimmunoassay. De novo synthesis of MCP-1 was demonstrated by
blocking MCP-1 synthesis with cycloheximide. The molecular weight of
MCP-1 produced by PTEC was determined by HPLC gel filtration and
found to be 13 kD. Taken together, these findings indicate that PTEC are
a source of MCP-1 and the increased expression of MCP-1 in renal tubular
epithelial cells in various types of glomerulonephritis may directly influ-
ence the degree of inflammation in the kidney.
Complement in serum and dialysate in children on CAPD. RE.
Reddingius, C.H. Schroder, MR. Daha, A.M. Koster, and L.A.H. Monnens,
Department of Pediatrics, University Hospital Nijmegen, Nijmegen, and
Department of Nephrology University Hospital Leiden, Leiden, The Nether-
lands. During continuous ambulatory peritoneal dialysis (CAPD) activa-
tion of complement in the peritoneal cavity could theoretically occur, with
inappropriately high or low levels of complement factors in dialysate as a
consequence. Low levels of complement in the peritoneal cavity could
impair host defense. Fifteen children treated with CAPD were studied.
Median age of these children was 8.1 years (range 2.1—13.2). They had
been on CAPD for a median period of 39.7 months (range 0.4—89.1). The
children did not suffer from peritonitis or other significant infections.
Seven complement factors (Clq, C3, C4, C3d, B, D, F) were simulta-
neously measured in dialysate and serum. Four non-complement proteins
(p2-microglobulin, albumin, IgG, a2-macroglobulin) were also measured.
Assuming a linear relationship between the log base 10 of molecular
weight and the log base 10 of the dialysate/serum ratio for these
non-complement proteins, the expected levels of the complement factors
were determined. Possible effects of molecular structure or charge were
neglected. The actual and expected dialysate/serum ratios were compared
with a modified t-test, taking into account the inaccuracy of the estimate.
The ratios of factor D (P < 0.001) and C3d (P = 0.02) were elevated,
whereas those of C3 (P < 0.001), C4 (P < 0.001), and factor P (P < 0.01)
were decreased. Relatively low dialysate levels of C4, C3 and factor P
could be caused by intraperitoneal consumption of complement. High
dialysate/serum ratios of C3d are a logical consequence of consumption of
C3. High ratios of factor D indicate intraperitoneal production of factor
D. These results provide evidence for activation of complement in the
peritoneal cavity in children on CAPD.
In vivo characterization of niuscarinic receptor subtypes in the forearm
vascular bed of patients with primary hypertension. TA Bruning, P.C.
Chang M.G.C. Hendriks, E.A.P. Kuypers, and PA van Zwieten, Depart-
ment of Pharmacotherapy, Academic Medical Centre, Amsterdam, and
Departments of Nephrology and Hospital Pharmacy, University Hospital
Leiden, Leiden, The Netherlands. Cholinergic vasodilation has been re-
ported to be attenuated in patients with primary and secondary hyperten-
sion. We have recently presented evidence for the muscarinic type-3 (M3)
receptor to predominate in the cholinergic vasodilator response in the
forearm of healthy volunteers. To investigate the role of muscarinic
receptor subtypes in the forearm resistance vasculature of 6 male patients
with primary hypertension and 6 matched normotensive controls (both
groups age 47 4 years; mean SE), we infused methacholine (MCh) in
the presence of saline, and the antagonists atropine (non-selective),
pirenzepine (M1-selective), and AF-DX 116 (M2-selective), using venous
occlusion plethysmography. Affinity constants (pKB values) were deter-
mined from calculated plasma concentrations of the infused compounds
and resulting EC50 values. Sodium nitroprusside (SNP) was given as an
endothelium-independent control. We found no differences between the
groups for SNP- and MCh-induced vasodilation, with apparent EC50
values (—log molar; mean SE) of 7.32 0.13 and 7.51 0.21
(hypertensives), and 7.37 0.13 and 7.45 0.02 (controls), respectively.
The concentration-response curve of MCh was shifted to the right by
atropine, pirenzepine, and by AF-DX 116, with apparent pKB values of
8.63 0.29, 6.81 0.13 and 5.51 0.08 (hypertensives), and 8.62 0.10,
6.98 0.08 and 5.49 0.09 (controls), respectively. Again, there were no
statistical differences between the groups. The affinity constants and rank
order of potency—atropine > pirenzepine > AF-DX 116—confirm that
cholinergic vasodilatation in this vascular bed is predominantly mediated
by the M3-receptor subtype. The vasodilator responses to both SNP and
MCh, as well as the functional characteristics (pKB values) proved
unchanged by the hypertensive state.
Inhibition of sodium transport in rabbit cortical collecting system by
extracellular ATP depends on protein kinase C activation. H.P.G. Koster,
C.H. van Os, and RIM Bindels, Department of Cell Physiology, University
of Nijmegen, Nijmegen, The Netherlands. Cells from the rabbit connecting
tubule and cortical collecting duct were isolated by immunodissection,
subsequently cultured on permeable filters and placed in Ussing chambers
in which short-circuit current (ISC) and transepithelial conductance (G)
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were measured. In all experiments, cells were pretreated for 15 hours with
i0 M aldosterone, which doubled 'Sc and G when compared to controls
12 3 vs. 27 3 jsA cm2; G, 1.8 0.3 vs. 3.1 0.4 mS cm2).
The Na channel blocker benzamil dose-dependently inhibited (1C50
= 5 X iO M). The benzamil-sensitive component of 'sc correlates with
active transepithelial Na transport. Extracellular ATP (10——10 M,
apical side) reduced active transcellular Na transport dose-dependently,
with a maximal inhibition of 60 5%. The rank order of potency of
nucleotide analogues for inhibition of Na transport was UTP = ATP>
ADP > AMP> adenosine, which suggests that the ATP effect is mediated
by P2-purinoceptors. At the cellular level, ATP (10—10— M) induced a
dose-dependent transient increase in intracellular [Ca2] ([Ca2I1), fol-
lowed by a sustained elevated level. Preloading the cells with the Ca2
chelator BAPTA completely prevented the ATP-induced Ca2 transients,
but ATP was still able to inhibit Na transport by 60%. This dissociation
between Ca2 transient and Na transport inhibition is explained by ATP
mediated activation of protein kinase C (PKC). Activation of PKC by the
cell permeable 1,2-dioctanoyl-sn-glycerol mimicked ATP-induced inhibi-
tion of transcellular Na" transport. The inhibitory effect of ATP was
completely abolished in PKC down-regulated cells. In conclusion, extra-
cellular ATP binds to an apically located P2-purinoceptor, which activates
phospholipase C and generates inositoltriphosphate (1P3) and diacylglyc-
erol. For inhibition of Na transport only activation of PKC by diacyl-
glycerol is needed, since the 1P3-induced Ca2 release and activation of a
Ca2" entry mechanism were not required.
Proteinuria and glomerular apolipoprotein (apo) deposition in unine-
phrectomized female analbuminemic rats. J.A. Joles, H. van Goor, H.A.
Koomans, and A. van Tol, Department of Nephrology, University Hospital
Utrecht, Utrecht; Department of Pathology, University Hospital Groningen,
Groningen; and Department of Biochemistry, Erasmus University, Rotter-
dam, The Netherlands. Female analbuminemic rats (NAR), as compared
to male NAR, are known for their hyperlipidemia. It is still unclear
whether hyperlipidemia per se contributes to the development of protein-
uria in hyperfiltering kidneys. To answer this question, 9 and NAR
were uninephrectomized (UnX) or sham-operated (2K). The 9 and
NAR developed comparable degrees of hyperfiltration: 1 hour EDTA and
24 hours creatinine clearances increased to values between 140 and 175%
and 150 and 195%, respectively, of the original one-kidney filtration at 4,
15, 25 and 31 weeks post-UnX. However, only the UnX female NAR
developed proteinuria (mg/day; mean SEM).
Weeks post-UnX
4 15 25 31
Proteinuria
UnX 9 (N 10) 6 0.4 5 0.4 34 17 141 37
2K9(N=8)
UnXd(N=8)
6±0.6
131b
6±0.2
11÷1b
12±4
13±1
17±7
15±2
Plasma cholesterol
mmol/liter
UnX 9 6.7 0.3 6.9 0.3 9.6 0.9 14.3 0.9a
2K 9 6.3 0.4 6.9 0.2 10.4 0.4 11.9 0.6
UnX 43 01h 43 0.l! 4.8 0.2" 6.4 0.5"
Plasma triglycerides
mmol/liter
UnX 9 3.1 0.3 2.7 0.3 3.1 0.3 6.0 1.3
2K 9 2.6 0.4 1.9 0.1 3.9 0.3 6.9 1.3
UnX d 1.8 01b 1.8 0.2" 1.4 0.1" 3.0 06b
UnX vs 2K: ap < 0.05; vs 9; "p <0.05.
Plasma (p) apo's and glomerular (G) apo's, lipid (GL), sclerosis (GS) and
diameters (Gd)) were assessed 37 weeks post-UnX.
p apo A-I p apo B GL score GS score Gd) lun
UnX 9 200 12 285 22 89 2P 30 ioa 174 3"
21(9 158±8 204±8 7±2 1±1 158±2
UnX & 81 7b 218 8b 4b 0" 190 7h
Strong apo A-I and trace B and E deposits in epithelium and weak
mesangial B and E deposits were observed in UnX 9 NAR, but not in 2K
9 NAR or NAR. Gd) were longest in UnX NAR. Thus, in the absence
of excessive hyperfiltration and glomerular hypertrophy, pre-existent
hyperlipidemia appears to contribute to proteinuria and GS after UnX in
female NAR.
Cryopreserved bone marrow cells after allogeneic kidney transplanta-
tion and European anti-thymocyte globulin do not induce tolerance in
non-human primates. A.A.M.J. Hollander, L. de Waal, H. van Bockel, M.
Jonker, F.H.J. Claas, M. van der Voort Maarschalk JA Bruijn, and F.J. van
der Woude, University Hospital Leiden, Leiden, and CLB, Amsterdam and
TNO-ITRI, Rijswij/.c, The Netherlands. According to Thomas et al, long-
term tolerance after allogeneic kidney transplantation can be achieved in
Rhesus monkeys with a 5 day course of anti-thymocyte globulin (ATG)
followed by the infusion of fresh donor bone marrow (BM) cells. The best
graft survival was found when MHC class II negative BM cells were
infused. If this same procedure were used in the postmortal donor setting,
donor BM cells would have to be stored for several days after the death of
the donor. To test whether tolerance induction is also possible with stored
(cryopreserved) donor BM cells in Rhesus monkeys after allogeneic
kidney transplantation, 9 female monkeys, which shared 1 DR antigen
with the male donor, received a kidney transplant. From days 0 to 4, ATG
(Fresenius) was given (50 mg/kg body wt). BM cells were MHC-DR
depleted with magnetic beads labeled with the monoclonal antibody L243.
The BM cells were frozen and stored in liquid nitrogen. On day 5 the
thawed donor-specific BM cells were infused in 5 kidney recipients (1.3 to
9.8 io viable cells/kg body wt. The control group (4 monkeys) did not
receive BM cells. No difference in graft survival was found between the
two groups. Mean graft survival in the BM group was 23.4 days versus 19.8
days in the control group. All grafts were lost due to rejection: interstitial
rejection in 3 control and 2 BM monkeys, vascular rejection in 2 BM
monkeys and interstitial and vascular rejection in 1 control and 1 BM
monkey. In both groups cytotoxic T lymphocyte precursor frequency(CTLp) against donor cells was low after transplantation and thus did not
predict rejection. In conclusion, ciyopreserved BM cells did not induce
tolerance in the Rhesus monkey-ATG-BM model. Before applying this
model in postmortal kidney transplantation in humans the effect of other
ATG preparations and methods of storage of donor BM cells need to be
further investigated.
Vasodilator effects of 1-desamino.8-D-arginine vasopressin (DDAVP)
in subjects with essential hypertension or autonomic failure. H.S. Brinlç
F.H.M Derlcç AL Man in't Veld, F. Boomsma, and M.A.D.H. Schalekamp,
Department of Internal Medicine I, Erasmus University, Rotterdam, The
Netherlands. In 8 healthy volunteers and 8 subjects with essential hyper-
tension, we compared the vasodilator effect of the selective vasopressin V2
receptor agonist DDAVP (400 ng/kg i.v. in 10 minutes). In the healthy
volunteers DDAVP caused a fall in diastolic blood pressure (DBP) of 10
(5—15) mm Hg (mean, 95% confidence interval, P < 0.001) without a
change in systolic blood pressure (SBP). Heart rate (HR) increased with
26 (15—37) bpm (P < 0.001). Plasma renin rose by 220% (132—309, P <
0.001) and noradrenaline (NA) by 110% (77—144, P < 0.001). In the
hypertensives, DDAVP caused not only a fall in DBP but also in SBP [13
(8—18) mm Hg, P < 0.005 between groups]. The effects on DBP, HR,
renin, and NA were the same in both groups. In 6 of the hypertensives
plasma DDAVP levels were measured. Peak plasma levels were 2.85
(1.93—4.22) ng/ml. Incremental lower doses of DDAVP were given to 10
subjects with essential hypertension and to 3 patients with orthostatic
hypotension due to peripheral autonomic neuropathy. Cumulative doses
were 12.5, 25, 50, 100, 200, and 400 ng/kg iv. at 15 minute intervals. In the
hypertensives the first significant effect on blood pressure was observed
after a cumulative dose of 100 ng/kg. SBP fell by 12 (5—20) mm Hg (P <
0.05) and DBP by 10 (5—15) mm Hg (P < 0.05). HR increased with 10
(6—15) bpm (P < 0.01), renin rose by 31% (11—50) (P < 0.05) and NA by
45% (27—62, P < 0.05). In the patients already with orthostatic hypoten-
sion, a cumulative dose of 25 ngfkg caused a significant fall in SBP of 16
(15—18) mm Hg (median, range) and in DBP of 8 (5—12) mm Hg. HR and
NA did not change. A rise in renin was observed in only 2 of the patients
after the 400 nglkg dose. Most likely, the rise in renin after DDAVP in
healthy volunteers and in hypertensives is secondary to sympathetic
stimulation. Our dose-response studies show that V2 receptor-mediated
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vasodilation occurs at plasma DDAVP levels similar to plasma AVP levels
under pathological conditions with stimulated AVP release.
Hantavirns nephropathy (HVN): Not just an arcane zoonosis. I
Clement, P. Colson, Ph. Damoiseau P. McKenna, J. Coeclç I Neyts, H.
Leirs, and R. Verhagen, Queen Astrid Militaty Hospital, Brussels, CS. des
Fagnes, Chimay, C.H. de Dinant, and RUCA, Antwerp, Belgium. During
1993, an epidemic recrudescence of HVN was noted in several European
countries, i.e. France, Germany and the Netherlands. During the most
important outbreak so far of HVN in Belgium, a total of 57 serologically
proven cases were registered from September 1992 through January 1994
in the Southern Ardennes. IgG IFA screening established a significantly
higher mean geometric titer of 989.1 for the "European" Hantavirus (MV)
serotype Puumala (PUU) versus only 72.5 for Hantaan (x2 = 37, P <
0.001), and 48.8 for Seoul (y = 33, P < 0.001), the latter being both
"Asian" serotypes. Micron capture 1gM EIA confirmed PUU as the
serotype involved in all acute samples. A very dense local population of
bank voles (the main rodent vector for PUU) was noted, probably related
to the abundance of beeehnuts (the staple food of voles) and the mild
1992—1993 winter. With a capture EIA, we found the presence of a
PUU-like antigen in a total of 10/160 (6%) voles trapped in June,
September and November 1993 around the habitats of HVN patients. All
other rodent species captured (total 94) were HV antigen negative.
Analysis of 34 completed clinical records disclosed fever in 100%,
lumbalgia in 79%, acute myopia in 26%, 5crcatinine >1.2 mg% in 88%
(range 1.1—9.9), and platelets <100,000/mi in 76%. A mild form of HVN
(SCr <1.2 mg%) was found in 12%, a moderate form (SCr 1.2—4 mg%) in
53% and a severe form (Se. >4 mg%) in 35%, but remission was the rule
in all eases. However, combined dialysis and mechanical ventilation was
necessary in 2 patients, 1 presenting with fluid overload, the other with
shock (BP 65/40 mm Hg), diffuse intravascular coagulation, internal
hemorrhages and adult respiratory distress syndrome (ARDS) (P02 40
mm Hg). Thus, European PUU-induced HYN may present with ARDS, a
feature hitherto considered specific for the current HV epidemic in the
USA.
Dialysnte CA125 in stable CAPD patients: No relation with transport
kinetics. MM. Pannekeet, G.J.M. Koomen, D.G. Struijlc and R.T. Krediet,
Academic Medical Center, Amsterdam, The Netherlands. Mesotheiial cells
are the most important source of CA125 in the peritoneal cavity. We have
shown previously that a relationship is present between the number of
mesothelial cells in the effluent of CAPD patients and its CA12S concen-
tration. It could be concluded from in vitro experiments that CA125 can be
regarded as a marker for the total mesotheliai cell mass, provided no cell
lysis occurs. We postulated that dialysate CA125 (dCA12S) in stable
CAPD patients is a reflection of mesothelial mass or mesothelial cell
turnover in vivo. We further studied the role of CA125 during stable
CAPD and its possible relation to peritoneal permeability. dCA125 was
determined in the effluent of 72 standard peritoneal permeability analyses
(SPA). SPA's were done during a 4 hour dwell using glucose 1.36%, and
in 34 of them dextran (70 g/iiter) was added to calculate fluid kinetics. The
patients had a median age of 52 years (range 21—76), the duration of
CAPD treatment was 25 months (1—132), and the peritonitis incidence was
1.2 episodes/year (0—7.8). Median dCAI25 was 15.0 U/mi (1.5—54.1). The
dCA125 was positiveiy related to age (P = 0.05) and negatively reiated to
the duration of CAPD (P = 0.0002). No correlation existed with sex (P =
0.91) or peritonitis incidence (P = 0.56). Also, no relationship was present
with the mass transfer area coefficient of creatinine, used as a functional
representation of the effective peritoneal surface area and with net
ultrafiltration (drained minus infused volume). A negative correlation was
found with the intrinsic permeability, expressed as the restriction coeffi-
cient (rc, P = 0.05). More data were available in 34 patients: neither
transcapiilary ultrafiltration rate, effective lymphatic absorption rate, the
resulting change in intraperitoneal volume (AIPV) nor the glucose
absorption were related to dCA125. A subgroup of patients (N = 24) had
CA125 values below 11 U/mI (log mean minus 1 su). They were treated
with CAPD for a longer period of time (24 vs. 16 months, P = 0.007), had
a lower AIPV (—97 vs. 52 ml, P = 0.03) and a higher re (2.40 vs. 2.22,
P = 0.0004). The mesothelium during CAPD shows signs of activation and
a high cell turnover. Loss of mesothelial cells has been reported during
peritonitis and in some patients on long-term CAPD. This is likely to be
the explanation for the relationship between low dCA125 levels and the
duration of CAPD. The other permeability characteristics of the low
dCA125 group (lower AIPV and higher re) are probably not directly
related to the mesothelial cell mass, but to the longer duration of dialysis,
as both have been reported previously to occur in long-term CAPD. In
conclusion, these findings indicate that mesothelial cell mass is negatively
related to duration of CAPD treatment, but that the mesothelial cells
probably do not play an important role in transport kinetics.
Effects of endothelin-l (ET-1) and nitric oxide (NO) stimulation on
renal function in humans. J.A. B4jlsma, A.J. Rabelinlç H.A.H. Kaasjager,
and H.A. Koomans, University Hospital Utrecht, Utrecht, The Netherlands.
Introduction: We recently demonstrated profound renal vasoconstrictive
and antinatriuretic effects of pathophysiological dosages of ET-1 in
humans. In isolated resistance arteries and in coronary arteries, NO is a
potent inhibitor of the vasoconstrictive effects of ET-1. We therefore
investigated whether stimulation of endogeneous NO by L-Arginine
(L-Arg) could also inhibit the renal effects of ET-1. Methods: Studies were
performed in 6 healthy subjects. Each subject underwent 3 clearance
studies, during which 90 minute infusions of ET-1 (2.5 ng/kg/min), L-Arg
(5 mg/kg/mm) and a combination of these were administered. This dosage
of L-Arg is an established NO stimulation test. Clearances were calculated
every 30 minutes. Parameters were mean arterial blood pressure (MAP),
renal vascular resistance (RVR), electrolyte and acid excretion, and
urinary NO2 excretion as an index of renal NO stimulation. Results:
MAP mm Hg RVRmm Hg mm/liter
Baseline InfusionBaseline Infusion
ET-1
L-Arg
ET + L-Arg
95.4 2.0 102.4 2.3
96.8±1.4 93.0±1.4
97.8 1.5 94.0±2.1
78 3 124 7
80±3 71±4
82±3 114±5
ET-1
L-Arg
ET+ L-Arg
Sodium excretion
i.mol/min
Chloride excretion
pmol/mmn
128±23 58±11
149±24 553±84
126±27 370±45
178±30 83±11
180±28 309±69
170±43 130±38
All observations during infusion were significantly different from base-
line, P < 0.05.
L-Arg prevented the increase in MAP during ET-1 infusion. However,
while L-Arg alone caused renal vasodilation and increased urinary NO2
excretion (from 62 21 to 405 169 pmol/min), L-Arg could not prevent
the increase in RVR during ET-1, despite a comparable increase in renal
NO2 excretion (from 112 30 to 465 190 pmol/min). In addition, ET-1
still caused sodium retention in the presence of L-Arg, while L-Arg alone
was natriuretic. In contrast, chloride excretion increased markedly during
L-Arg, both with andwithout ET-1. This is explained by excretion of acid,
secondary to metabolism of Arg-HCI. Conclusion: In humans, endoge-
neous NO stimulation by L-Arg prevents the increase in blood pressure,
but cannot prevent the renal vasoeonstriction caused by pathophysiolog-
ieal amounts of ET-1.
Effect of sex and age on kidney graft survIval. Essential role of the
number of nephrons at the start of transplantation. E.P.M van Steen-
berge, P.G. Mulder, J.N. Ijzermans, and W. Weimar, Department of Internal
Medicine I, Department of Epidemiology and Biostatistics and Department of
General Surgery, University Hospital Rotterdam, Rotterdam, The Nether-
lands. To assess pretransplant prognostic factors associated with long-term
kidney transplant outcome, we analyzed all 591 consecutive first cadaveric
kidney transplantations performed between July 1972 and July 1992 at our
center, with follow-up completed to December 31, 1993. Proportional
hazards analysis was used to estimate the relative risks of the covariates
associated with functional graft, patient and overall graft survival. Factors
having no influence on any outcome included: cause of death of the donor,
warm and cold ischemia times, the method of kidney preservation,
recipient sex and recipient blood group. The factors associated with
functional graft failure were: donor-recipient age difference >0 (relative
risk 1.63, P = 0.07), and the female sex of the donor (relative risk 1.48, P
= 0.013). The female sex of the donor (relative risk 1,78, P = 0.004) and
each additional year in recipient age (relative risk 1.07, P < 0.001)
provided the highest risk of patient death. The recipients of relatively
older donor kidneys had the highest risk of overall graft failure (relative
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risk 1.68, P = 0.02). The sex of the donor (relative risk 1.56, P < 0.001),
each additional mismatch on the HLA ABDR loci (relative risk 1.12,
P = 0.045), and recipient age (relative risk 1.02, P = 0.01) also had
significant, HLA independent, effects on the overall graft survival. It is
likely that both vulnerability to ischemia and aging factors of the female
donor kidneys reduce the number of functioning nephrons and are
responsible for the donor sex effect. Matching for age could improve the
graft outcome of the high risk female donors.
Sodium homeostasis and dopamine excretion in HLA-identical kidney
donors and recipients. J.N.M Barendregt, L. van Nispen, and P.C. Chang,
Department of Nephrology, University Hospital Leiden, Leiden, The Nether-
lands. Intrarenal dopamine (DA) synthesis may be involved in sodium
homeostasis. In 7 HLA-identical kidney recipient-donor couples and 1
unrelated pair, we investigated hemodynamic and hormonal parameters
and excretion of catechols and sodium at 50 (LoSo), 150 (NoSo), and 300
(HiSo) mmol day of dietary sodium intake. We infused trimethaphan
to mimic acute denervation, DOPA (0.15 tg kg1 .min') to study
DOPA to DA conversion and tyramine in subpressor and pressor doses
(3.3 and 10 sg kg1 min1) to induce norepinephrine release. Blood
pressure was higher in the recipients (P < 0.05) and was not influenced by
sodium intake. UNaV did not differ between recipients and donors at
LoSo, NoSo, and HiSo (37 5, 132 7, and 312 19 mmol day').
UDAV did not increase on HiSo in both groups. The UDA/UDOPA ratio was
higher in donors than in recipients (P < 0.01) and suppressed in both
groups on HiSo (P < 0.05). Trimetaphan decreased RVR and increased
UNaV only in the donors (P < 0.05), while GFR increased in both groups.
DOPA infusion increased UDAV 4—5 fold but did not change UNaV in
either group. Tyramine increased the UDA/UDOPA in donors (P < 0.05).
The absence of a natriuretic response to DOPA and the absence of an
increase in UDAV on HiSo indicate that intrarenal DA generation plays
only a small role in sodium homeostasis. Evidence regarding the presence
of functional renal reinnervation in grafted kidneys remains inconclusive.
Norepinephrine release from sympathetic nerves may stimulate intrarenal
DOPA to DA conversion.
Monoclonal anti-interleukin-2 receptor antibody (BT563) prevents
early rejection after kidney transplantation. A double-blind, placebo-
controlled trial. T. van Gelder, R. Zietse, J.N.M Yzermans, L.MB. Vaessen,
A.H. Mulder, and W. Weimar, Departments of Internal Medicine I, Swgey
and Pathology, University Hospital Rotterdam, Rotterdam, The Netherlands.
Sixty-one kidney allograft recipients were randomized in a prospective,
double-blind, placebo-controlled trial of BT563 (a murine IgG1 monoclo-
nal antibody directed against the 55 lcD chain of the interleukin-2
receptor) in the prophylaxis of rejection. The study medication was given
in a dosage of 10 mg iv. during the first 10 days after transplantation.
Maintenance immunosuppression consisted of cyclosporine and pred-
nisone. Clinical tolerance was excellent: no patient experienced significant
side effects. In the first 4 weeks after transplantation an acute rejection was
diagnosed in 7/30 (23%) of placebo-treated patients compared to 1/27
(4%) of BT563-treated patients (P < 0.05; log-rank test). All 7 rejections
in the placebo group occurred within the first 10 days, during the
placebo-treatment period, whereas during BT563-treatment no rejections
were found. Another rejection was found in the placebo-group between
week 5 and week 12 and 2 rejections in the BT563-group were found in
this period. All rejections in the BT563 group were reversible with
treatment (steroids and/or r-ATG), whereas in the placebo group rejec-
tion led to graft loss in 2 cases. Infectious complications were comparable
in both groups and consisted mainly of urinary tract infections (12 in
placebo vs. 16 in BT563 group in first 12 weeks) and CMV disease (3 in
placebo vs. 0 in BT563 group in first 12 weeks). In the BT563 group, 3
grafts were lost due to renal artery thrombosis. One placebo-treated
patient died at day 32 post-Tx of acute necrotizing pancreatitis, and
another placebo-treated patient had a non-fatal myocardial infarction at
the second post-operative day. We conclude that the use of the anti-IL-2R
monoclonal BT563 leads to a significant reduction in the incidence of
acute rejections after kidney transplantation, without side effects or an
increased incidence of infectious complications. The complete absence of
acute rejections during BT563 administration may be the result of
combining cyclosporine and anti-IL-2R MoAb, a combination that was
shown to have a synergistic immunosuppressive effect in animal models.
Compassionate treatment of Wegener's granulomatosis with rabbit
anti-thymocyte globulin (ATG). E.G. Hagen, R.J. W. de Keizer, W.P.L. van
Boven, K Andrassy, J.A. Bruijn, L.A. van Es, and F.J. van der Woude,
Department of Nephrology, Ophthalmology and Pathology, University Hos-
pital Leiden, Leiden, St. Elisabeth Ziekenhuis, Tilburg The Netherlands; and
Department of Nephrology, University of Heidelbeig, Heidelbeig, Germany.
This study aimed to evaluate the effect of treatment with ATG in patients
with Wegener's granulomatosis, untreatable with cyclophosphamide and
steroids. Five patients with active Wegener's granulomatosis who were
either not responsive to standard therapy, or who could not tolerate
alkylating agents were treated with a single course of rabbit ATG. Four
out of 5 patients showed a favorable response to treatment, with partial or
complete remission of disease activity, with a follow-up period of 6 to 13
months. One patient had progressive retroorbital granuloma, which
resulted in enucleation of the eye. Side effects were mild, with chills and
fever during the first infusion of ATG, and development of serum sickness
in 2 patients. Two patients had labial herpes simplex shortly after the start
of treatment. No other infectious complications were seen. We conclude
that ATG treatment seems to be an effective treatment for patients with
severe Wegener's granulomatosis.
